Onderneming Avricore Health Inc Toronto S.E.
Aandelen
APH
CA92143R2046
Farmaceutische producten
Vakgebied
Verkoop per activiteit
CAD in miljoen | 2021 | Gewicht | 2022 | Gewicht | Delta |
---|---|---|---|---|---|
Health Data and Point-of-care Technologies
100,0
%
| 0 | 100,0 % | 2 | 100,0 % | +1.339,95% |
Verkoop per regio
CAD in miljoen | 2021 | Gewicht | 2022 | Gewicht | Delta |
---|---|---|---|---|---|
Canada
100,0
%
| 0 | 100,0 % | 2 | 100,0 % | +1.339,95% |
Managers
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Hector Bremner
CEO | Chief Executive Officer | - | 01-01-19 |
Kiki Smith
DFI | Director of Finance/CFO | - | 06-08-19 |
Rodger Seccombe
CTO | Chief Tech/Sci/R&D Officer | - | 08-12-20 |
Mark Kunzli
PRN | Corporate Officer/Principal | - | - |
Besturend
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
David Hall
CHM | Chairman | 71 | 20-01-16 |
Robert Sindelar
BRD | Director/Board Member | 71 | 27-03-18 |
Christine Hrudka
BRD | Director/Board Member | - | 21-06-23 |
Rodger Seccombe
CTO | Chief Tech/Sci/R&D Officer | - | 08-12-20 |
Alan Arnstein
BRD | Director/Board Member | 56 | 20-04-17 |
Hector Bremner
CEO | Chief Executive Officer | - | 01-01-19 |
Thomas Teahen
BRD | Director/Board Member | - | 21-06-23 |
Aandelenklasse
Stemming | Aantal | Vrij verhandelbaar | Bedrijfseigen aandelen | Drijvend Totaal | |
---|---|---|---|---|---|
Aandeel A | 1 | 99 869 664 | 90 194 935 ( 90,31 %) | 0 | 90,31 % |
Bedrijfsgegevens
Avricore Health, Inc.
789 West Pender Street Suite 1120
V6C 1H2, Vancouver
+
http://www.avricorehealth.comSector
Vaira. 1 jan. | Kapi. | |
---|---|---|
+21,85% | 546 mld. | |
-4,77% | 359 mld. | |
+16,97% | 323 mld. | |
+5,69% | 290 mld. | |
+13,68% | 234 mld. | |
+3,65% | 198 mld. | |
-11,12% | 194 mld. | |
+8,08% | 167 mld. | |
-3,40% | 157 mld. |